DeepRhythmAI vs Tempus ECG-AF
AI Verdict
Choose DeepRhythmAI if…
Choose DeepRhythmAI if your primary need is highly accurate and efficient detection and classification of a broad range of cardiac arrhythmias from diverse ECG data sources. This cloud-based solution is ideal for healthcare providers seeking to significantly reduce missed diagnoses and streamline their ECG reporting workflows across various devices.
View DeepRhythmAI →Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if your goal is to proactively identify elderly patients (65+) at increased risk of developing new-onset atrial fibrillation within the next 12 months. This tool is specifically designed for risk stratification in a defined patient population, allowing for earlier identification and follow-up to potentially prevent future AF events.
View Tempus ECG-AF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | DeepRhythmAI | Tempus ECG-AF |
|---|---|---|
| Pricing | Contact vendor for pricing information | Contact vendor |
| Deployment | Cloud-based, hardware-agnostic, SaaS, on-prem, hybrid | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
DeepRhythmAIDeepRhythmAI (Tool A) is a cloud-based, device-agnostic solution with an API, offering greater flexibility for integration into diverse healthcare workflows and existing ECG devices. While it lacks a native user interface, its design for seamless integration with external visualization software enhances its adaptability and streamlines clinical processes. Tempus ECG-AF (Tool B) is integrated into facility systems and compatible with specific ECG devices, which may imply a more rigid deployment.
Clinical Value
DeepRhythmAIDeepRhythmAI (Tool A) offers superior accuracy in detecting and classifying a wide range of cardiac arrhythmias from ECG data, significantly reducing missed diagnoses by 14x to 114x. This provides a broad and immediate clinical impact across various arrhythmia types. Tempus ECG-AF (Tool B) focuses on predicting the risk of new-onset atrial fibrillation in a specific demographic, which is valuable but more specialized in its application.
Pricing & Value
Tempus ECG-AFTempus ECG-AF (Tool B) clearly outlines its financial value by stating CMS reimbursement availability with specific CPT codes (0764T and 0765T) and a Medicare rate of $128.90, effective January 1, 2025. This transparency provides a clear pathway for adoption and financial planning for healthcare providers. DeepRhythmAI (Tool A) only states 'enterprise' pricing with unknown details, making its value proposition less clear.
Enterprise Readiness
DeepRhythmAIDeepRhythmAI (Tool A) demonstrates strong enterprise readiness with explicit compliance certifications including HIPAA, GDPR, HITECH, SOC 2, and ISO 27001. Its cloud deployment, API availability, and global customer base further support its scalability and integration capabilities for various health systems. Tempus ECG-AF (Tool B) is HIPAA compliant and offers a BAA, but lacks the broader set of certifications.
Innovation
DeepRhythmAIDeepRhythmAI (Tool A) showcases a higher degree of technical innovation by explicitly mentioning its use of advanced AI models like Convolutional Neural Networks (CNNs) and Transformer models, trained on an exceptionally large dataset of 250 billion+ annotated heartbeats. This robust foundation supports its claim of revolutionizing cardiac arrhythmia detection and classification. Tempus ECG-AF (Tool B) is AI-based for predictive risk, but provides less detail on its underlying technical sophistication or data scale.
Support & Docs
TieNeither DeepRhythmAI (Tool A) nor Tempus ECG-AF (Tool B) provide specific details regarding their customer support channels, the availability or quality of documentation, or training resources in the provided facts or through web search. Therefore, it is not possible to distinguish between the two on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | DeepRhythmAI | Tempus ECG-AF |
|---|---|---|
| Name | DeepRhythmAI | Tempus ECG-AF |
| Company | Medicalgorithmics S.A. | Tempus AI, Inc. |
| Description | FDA-cleared, cloud-based AI algorithm that revolutionizes cardiac arrhythmia detection and classification from ECG data, offering superior accuracy and efficiency for physicians. | FDA-cleared AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months, supporting earlier identification and follow-up. |
| Key Functionality | AI-powered arrhythmia detection and classification from ECG data. | AI-based algorithm for 12-lead ECG analysis to detect signs associated with new onset Atrial Fibrillation (AF) within 12 months. |
| Target Patient Population | Adult patients | Patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery. |
| ECG Data Used | ECG data (Holter, Event, and Mobile Cardiac Telemetry data) | 12-lead ECG recordings |
| Training Data | 250 billion+ annotated heartbeats | Over 1.5 million ECGs from over 500,000 patients |
Videos
Demos, reviews, and walkthroughs featuring DeepRhythmAI and Tempus ECG-AF.